Table 2.

Risk of unfavorable outcomes of participants associated with NLR and PLR.

Variables	n	Unfavorable outcomes, # (%)	Crude		Adjusted
			HR (95% CI)	P-value	HR (95% CI)	P-value
Per SD increment of NLR	448	130 (29.02%)	1.72 (1.47, 2.00)	<0.001	1.51 (1.27, 1.80)	<0.001
Quartile
Q1 (<1.80)	112	9 (8.04)	1.00 (1.00, 1.00)	Ref.	1.00 (1.00, 1.00)	Ref.
Q2 (1.80 2.62)	112	18 (16.07)	1.96 (0.88, 4.36)	0.010	1.710 (0.732, 3.996)	0.215
Q3 (2.64 4.06)	112	32 (28.57)	3.57 (1.71, 7.49)	0.001	3.475 (1.579, 7.648)	0.002
Q4 (≥4.06)	112	71 (63.39)	8.34 (4.17, 16.70)	<0.001	6.121 (2.887, 12.977)	<0.001
P for trend				<0.001		<0.001
Per SD increment of PLR	448	130 (29.02%)	1.63 (1.35, 1.95)	<0.001	1.61 (1.29, 2.00)	<0.001
Q1 (<103.20)	112	17 (15.18)	1.00 (1.00, 1.00)	Ref.	1.00 (1.00, 1.00)	Ref.
Q2 (103.21 134.29)	112	20 (17.86)	1.15 (0.60, 2.20)	0.674	1.47 (0.74, 2.91)	0.270
Q3 (134.91 185.66)	112	35 (31.25)	1.85 (1.04, 3.30)	0.038	2.42 (1.30, 4.49)	0.005
Q4 (≥186.02)	112	58 (51.79)	3.18 (1.85, 5.47)	<0.001	3.54 (1.91, 6.54)	<0.001
P for trend				<0.001		<0.001

Adjusted for age, hypertension, atrial fibrillation, NIHSS score on admission, stroke etiologic subtypes, FBG, BUN, anticoagulation agents.